Every SEC Form 3/4/5 on record for this filer (CIK 1255927) — 13 issuers, 46 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | Director | 2019-05-01 → 2026-05-22 | 13 | $3M |
| MRNA | Moderna, Inc. | 10% owner · lapsed | 2018-12-07 → 2020-01-14 | 5 | −$12M |
| AXLA | Axcella Health Inc. | 10% owner · lapsed | 2019-05-08 → 2019-05-15 | 2 | — |
| KLDO | Kaleido Biosciences, Inc. | 10% owner · lapsed | 2019-02-27 → 2019-03-06 | 2 | — |
| RUBY | Rubius Therapeutics, Inc. | 10% owner · lapsed | 2018-07-17 → 2018-07-23 | 2 | — |
| EVLO | Evelo Biosciences, Inc. | 10% owner · lapsed | 2018-05-08 → 2018-05-15 | 2 | — |
| QTRX | Quanterix Corp | 10% owner · lapsed | 2017-12-06 → 2017-12-13 | 2 | — |
| SYRS | Syros Pharmaceuticals, Inc. | 10% owner · lapsed | 2016-06-29 → 2017-08-21 | 3 | — |
| SELB | SELECTA BIOSCIENCES INC | Director · lapsed | 2016-06-21 → 2017-05-16 | 3 | −$4M |
| EBIO | Eleven Biotherapeutics, Inc. | 10% owner · lapsed | 2016-09-08 → 2016-09-26 | 4 | −$1M |
| EDIT | Editas Medicine, Inc. | 10% owner · lapsed | 2016-02-02 → 2016-08-15 | 3 | — |
| MCRB | Seres Therapeutics, Inc. | 10% owner · lapsed | 2016-05-27 → 2016-05-27 | 1 | — |
| BGMD | BG Medicine, Inc. | 10% owner · lapsed | 2015-07-16 → 2015-07-16 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TMDX | 2021-11-29 | Buy | 74,062 | $22.71 | $2M | 302,893 |
| TMDX | 2021-11-29 | Buy | 25,938 | $22.14 | $574,267 | 228,831 |
5 of 13 issuers are covered and open a security page; the rest are on file here only.
